{"schema_version":"secwatch.filing_event.v1","accession":"0001428336-24-000009","form_type":"8-K","ticker":"HQY","cik":"0001428336","company_name":"HEALTHEQUITY, INC.","filed_at":"2024-03-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.163175+00:00","generated_at":"2026-06-04T13:13:07.414945+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"HealthEquity FY2024 revenue $999.6M (+16%), net income $55.7M vs loss; Q4 beat; guides FY2025 rev ~$1.15B","bullets":["FY 2024 revenue $999.6M (+16% YoY); net income $55.7M vs loss $26.1M; GAAP EPS $0.64 vs -$0.31.","Q4 revenue $262.4M (+12%); net income $26.4M vs loss; adj EBITDA $98.8M (+34%, margin 38%).","HSA accounts 8.7M (+9%), assets $25.2B (+14%); total accounts 15.7M.","Acquired first BenefitWallet tranche: 266k HSAs, $1.1B assets for $163.9M cash; $425M total deal.","FY 2025 guidance: rev $1.14-1.16B; adj EBITDA $438-458M; non-GAAP EPS $2.79-2.96."],"urls":{"canonical":"https://secwatch.observer/filing/0001428336-24-000009","json":"https://secwatch.observer/filing/0001428336-24-000009.json","markdown":"https://secwatch.observer/filing/0001428336-24-000009.md","text":"https://secwatch.observer/filing/0001428336-24-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/0001428336-24-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/hqy-20240319.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T13:13:07.414945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f8b6489faf17d14be2f71a467de060eb4c95885","claim":"HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2024 results: revenue $999.6 million, net income $55.7 million, EPS $0.64 per diluted share.","evidence_excerpt":"--- EX-99.1 (EX-99.1) --- HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results Highlights of the fiscal year include: • Revenue of $999.6 million, an increase of 16% compared to $861.7 million in FY23. • Net income of $55.7 million, compared to net loss of $26.1 million in FY23, with non-GAAP net income of $195.5 million,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/0001428336-24-000009-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended January 31, 2024"},{"label":"Revenue","value":"$999.6 million"},{"label":"Net income","value":"$55.7 million"},{"label":"EPS","value":"$0.64 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"871599682086526beaac79eed3e65c4761cf7869","claim":"HEALTHEQUITY, INC. reported the fourth quarter ended January 31, 2024 results: revenue $262.4 million, net income $26.4 million, EPS $0.30 per diluted share.","evidence_excerpt":"Revenue for the fourth quarter ended January 31, 2024 was $262.4 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833624000009/0001428336-24-000009-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended January 31, 2024"},{"label":"Revenue","value":"$262.4 million"},{"label":"Net income","value":"$26.4 million"},{"label":"EPS","value":"$0.30 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}